Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financi...(on to update anyforward-looking statemen...)

JAZZ PHARMACEUTICALS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)

Three Months Ended Year Ended

December 31, December 31,

2007 2006 2007 2006

Revenues:

Product sales, net $14,860 $11,890 $53,536 $43,299

Royalties, net 332 258 1,156 594

Contract revenue 285 301 10,611 963

Total revenues 15,477 12,449 65,303 44,856

Operating expenses:

Cost of product sales

(excluding amortization of

acquired developed

technology) 3,283 1,601 8,903 6,968

Research and development 20,540 13,036 69,792 54,956

Selling, general and

administrative 27,958 12,543 78,540 51,384

Intangible asset

amortization 2,280 2,400 9,217 9,600

Intangible asset impairment 20,160 - 20,160 -

Provision for government

settlement - - 17,469 -

Total operating expenses 74,221 29,580 204,081 122,908

Loss from operations (58,744) (17,131) (138,778) (78,052)

Interest income 1,582 619 5,942 2,307

Interest expense (3,554) (3,311) (13,647) (14,129)

Other income (expense)
'/>"/>